Traitement

Unlike aBC where the objective of the treatment is to delay progression and prolong life, the goal of eBC treatment is to cure the patient.^1,2 

ebc6.png

^{References: 1 and 2}

Treatment for breast cancer can be broadly classified into local or systemic therapy.³

ebc7.png

^{References: 3 and 4}

Multiple factors drive treatment decisions for eBC.³

ebc8.png

^{References: 3}

Endorcrine-based systemic therapy is a standard component of HR+/HER2-eBC treatment, regardless of if CT is indicated or not.⁴

ebc9.png

^{References: 4}

Adjuvant systemic therapies for HR+/HER2- breast cancer include:

ebc10.png

^{References: 4, 5, 6, and 7}

^{CDK 4/6, cyclin-dependent kinase 4/6; eBC, early breast cancer; gBRCA, germline breast cancer gene;
HER2, human epidermal growth factor receptor 2; HR, hormone receptor; PARP, poly-ADP ribosepolymeras}